Search

Your search keyword '"Tamamis, P"' showing total 93 results

Search Constraints

Start Over You searched for: Author "Tamamis, P" Remove constraint Author: "Tamamis, P"
93 results on '"Tamamis, P"'

Search Results

51. Selective 8-oxo-rG stalling occurs in the catalytic core of polynucleotide phosphorylase (PNPase) during degradation.

52. Chlorophyll-Amended Organoclays for the Detoxification of Ochratoxin A.

53. Co-Assembly of Cancer Drugs with Cyclo-HH Peptides: Insights from Simulations and Experiments.

54. Adsorption and removal of polystyrene nanoplastics from water by green-engineered clays.

55. Sequence-based identification of amyloidogenic β-hairpins reveals a prostatic acid phosphatase fragment promoting semen amyloid formation.

56. Characterization of epitranscriptome reader proteins experimentally and in silico : Current knowledge and future perspectives beyond the YTH domain.

57. Development and characterization of chlorophyll-amended montmorillonite clays for the adsorption and detoxification of benzene.

58. Computational design of a β-wrapin's N-terminal domain with canonical and non-canonical amino acid modifications mimicking curcumin's proposed inhibitory function.

59. Montmorillonite clay-based sorbents decrease the bioavailability of per- and polyfluoroalkyl substances (PFAS) from soil and their translocation to plants.

60. Computational and Experimental Protocols to Study Cyclo-dihistidine Self- and Co-assembly: Minimalistic Bio-assemblies with Enhanced Fluorescence and Drug Encapsulation Properties.

61. Modification of a Single Atom Affects the Physical Properties of Double Fluorinated Fmoc-Phe Derivatives.

62. Self-Assembled Peptide Nano-Superstructure towards Enzyme Mimicking Hydrolysis.

63. Hydroxylated Chalcones as Aryl Hydrocarbon Receptor Agonists: Structure-Activity Effects.

64. Enhanced adsorption of per- and polyfluoroalkyl substances (PFAS) by edible, nutrient-amended montmorillonite clays.

65. Insights into the interactions of bisphenol and phthalate compounds with unamended and carnitine-amended montmorillonite clays.

66. Enhanced Fluorescence for Bioassembly by Environment-Switching Doping of Metal Ions.

67. Amyloid Peptide Scaffolds Coordinate with Alzheimer's Disease Drugs.

68. Computational evolution of an RNA-binding protein towards enhanced oxidized-RNA binding.

69. Designer Amyloid Cell-Penetrating Peptides for Potential Use as Gene Transfer Vehicles.

70. Montmorillonites Can Tightly Bind Glyphosate and Paraquat Reducing Toxin Exposures and Toxicity.

71. Activation of COUP-TFI by a Novel Diindolylmethane Derivative.

72. Elucidating the multi-targeted anti-amyloid activity and enhanced islet amyloid polypeptide binding of β -wrapins.

73. A high-throughput and rapid computational method for screening of RNA post-transcriptional modifications that can be recognized by target proteins.

74. Structure-Dependent Modulation of Aryl Hydrocarbon Receptor-Mediated Activities by Flavonoids.

75. Virtual Screening of Chemical Compounds for Discovery of Complement C3 Ligands.

76. A novel amyloid designable scaffold and potential inhibitor inspired by GAIIG of amyloid beta and the HIV-1 V3 loop.

77. Molecular Modeling of Chemoreceptor:Ligand Interactions.

78. Princeton_TIGRESS 2.0: High refinement consistency and net gains through support vector machines and molecular dynamics in double-blind predictions during the CASP11 experiment.

79. Highly Accurate Structure-Based Prediction of HIV-1 Coreceptor Usage Suggests Intermolecular Interactions Driving Tropism.

80. Forcefield_NCAA: ab initio charge parameters to aid in the discovery and design of therapeutic proteins and peptides with unnatural amino acids and their application to complement inhibitors of the compstatin family.

81. Elucidating a key anti-HIV-1 and cancer-associated axis: the structure of CCL5 (Rantes) in complex with CCR5.

82. Princeton_TIGRESS: protein geometry refinement using simulations and support vector machines.

83. Elucidating a key component of cancer metastasis: CXCL12 (SDF-1α) binding to CXCR4.

84. Molecular recognition of CCR5 by an HIV-1 gp120 V3 loop.

85. Self-assembly of an aspartate-rich sequence from the adenovirus fiber shaft: insights from molecular dynamics simulations and experiments.

86. Combination of theoretical and experimental approaches for the design and study of fibril-forming peptides.

87. Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures.

88. Molecular dynamics in drug design: new generations of compstatin analogs.

89. Design of a modified mouse protein with ligand binding properties of its human analog by molecular dynamics simulations: the case of C3 inhibition by compstatin.

90. UV resonance Raman study of TTR(105-115) structural evolution as a function of temperature.

91. Species specificity of the complement inhibitor compstatin investigated by all-atom molecular dynamics simulations.

92. Amyloid-like self-assembly of peptide sequences from the adenovirus fiber shaft: insights from molecular dynamics simulations.

93. Conformational analysis of compstatin analogues with molecular dynamics simulations in explicit water.

Catalog

Books, media, physical & digital resources